Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|December 30, 2011
An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathwayZhican Wang, Yvonne S Lin, Xi Emily Zheng, et al.
The Journal of Nutrition|December 15, 2015
Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup'ik Study Population from Southwestern AlaskaAlison E Fohner, Zhican Wang, Joseph Yracheta, et al.
Kidney International|August 14, 2016
Development of a microphysiological model of human kidney proximal tubule functionElijah J Weber, Alenka Chapron, Brian D Chapron, et al.
Stem Cell Research & Therapy|February 26, 2014
Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion systemEdward J Kelly, Zhican Wang, Jenna L Voellinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2018
Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D<sub>3</sub>-3-<i>O</i>-Sulfate, a Major Circulating Vitamin D Metabolite in HumansTimothy Wong, Zhican Wang, Brian D Chapron, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2020
Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary DiseaseDavid A Jolliffe, Christos Stefanidis, Zhican Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 8, 2014
Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trialsIan H de Boer, Michael C Sachs, Michel Chonchol, et al.
Journal of Medicinal Chemistry|March 8, 2025
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted CancersJames Cregg, Anne V Edwards, Stephanie Chang, et al.
Cancer Discovery|June 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant CancersKyle J Seamon, Yongxian Zhuang, Yu Chi Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 TrialAlison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Pageof 4